Invesco Ltd. - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 106 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$272,069
-35.3%
39,718
-2.1%
0.00%
Q2 2023$420,701
+36.4%
40,569
+6.4%
0.00%
Q1 2023$308,529
-29.5%
38,137
+37.3%
0.00%
Q4 2022$437,583
-4.0%
27,783
-4.1%
0.00%
Q3 2022$456,000
+31.8%
28,985
+17.0%
0.00%
Q2 2022$346,000
-16.6%
24,769
+2.9%
0.00%
Q1 2022$415,000
+17.2%
24,076
-1.1%
0.00%
Q4 2021$354,000
-95.5%
24,339
-94.5%
0.00%
-100.0%
Q3 2021$7,898,000
+2156.6%
438,802
+2103.3%
0.00%
Q2 2021$350,000
-98.5%
19,916
-97.8%
0.00%
-100.0%
Q1 2021$22,857,000
+3678.0%
907,034
+870.4%
0.01%
Q4 2020$605,000
+141.0%
93,472
-4.1%
0.00%
Q3 2020$251,000
+54.0%
97,516
-3.2%
0.00%
Q2 2020$163,000
+37.0%
100,740
-12.2%
0.00%
Q1 2020$119,000
+133.3%
114,757
+321.6%
0.00%
Q4 2019$51,000
+64.5%
27,217
-6.2%
0.00%
Q3 2019$31,000
-53.0%
29,022
-3.8%
0.00%
Q2 2019$66,000
-64.7%
30,162
-3.4%
0.00%
Q1 2019$187,000
-97.6%
31,234
-94.3%
0.00%
-100.0%
Q3 2018$7,904,000
-31.3%
544,334
-5.5%
0.00%
-50.0%
Q2 2018$11,502,000
+14.0%
575,965
+0.0%
0.00%0.0%
Q1 2018$10,091,000
-30.1%
575,954
-1.6%
0.00%
-20.0%
Q4 2017$14,432,000
-4.4%
585,254
+0.0%
0.01%
-16.7%
Q3 2017$15,104,000
-8.6%
585,197
-4.0%
0.01%
+20.0%
Q2 2017$16,533,000
-15.3%
609,600
-6.9%
0.01%
-16.7%
Q1 2017$19,531,000
+15.3%
654,976
+4.9%
0.01%0.0%
Q4 2016$16,944,000624,3230.01%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders